Key Dates
- Board Meeting Date: Tuesday, August 04, 2026
- Quarter Ended: June 30, 2026 (Q1 FY27)
- Trading Window Closure: In effect until 48 hours after the announcement of the financial results
- Earnings Conference Call: August 04, 2026, from 05:30 PM IST to 06:30 PM IST
Purpose of Board Meeting
The Board of Directors will meet to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026.
Trading Window Status
The Trading Window remains closed as per the Company's Code of Conduct for Prevention of Insider Trading, effective until 48 hours after the financial results are announced.
Earnings Conference Call Details
The company will host a conference call for investors and analysts on August 04, 2026, at 05:30 PM IST.
Company Representatives on the call:
- Dr. Adil Agarwal – Whole-time Director and Chief Executive Officer
- Mr. Yashwanth Venkat – Chief Financial Officer
- Ms. Aashna Dharia – Head, Investor Relations
Dial-in Details:
- India: +91 22 6280 1308 / +91 22 7115 8161
- International Toll-Free numbers provided for multiple countries including Argentina, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Japan, Netherlands, Poland, Singapore, South Korea, Sweden, Thailand, UK, and USA.
- Express Join Diamond Pass URL: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4978397&linkSecurityString=2a208edf18
Additional Information
This intimation has been communicated to BSE Limited and National Stock Exchange of India Limited. The information is also available on the company's website at https://dragarwals.co.in/dr-agarwals-health-care/#corporate-announcement.
Financial Impact
Financial results for the quarter are pending board approval. Impact will be known after the board meeting on August 04, 2026.